Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Najjar SM, Russo L.

Semin Immunopathol. 2014 Jan;36(1):55-71. doi: 10.1007/s00281-013-0407-3. Epub 2013 Nov 21.

PMID:
24258517
[PubMed - in process]
2.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
[PubMed - indexed for MEDLINE]
3.

Non-alcoholic steatohepatitis in children.

Nanda K.

Pediatr Transplant. 2004 Dec;8(6):613-8. Review.

PMID:
15598336
[PubMed - indexed for MEDLINE]
4.

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.

Farrell GC, van Rooyen D, Gan L, Chitturi S.

Gut Liver. 2012 Apr;6(2):149-71. doi: 10.5009/gnl.2012.6.2.149. Epub 2012 Apr 17.

PMID:
22570745
[PubMed]
Free PMC Article
5.

Etiopathogenesis of nonalcoholic steatohepatitis.

Chitturi S, Farrell GC.

Semin Liver Dis. 2001;21(1):27-41. Review.

PMID:
11296694
[PubMed - indexed for MEDLINE]
6.

Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.

Ghosh S, Kaw M, Patel PR, Ledford KJ, Bowman TA, McInerney MF, Erickson SK, Bourey RE, Najjar SM.

Hepat Med. 2010 May;2010(2):69-78.

PMID:
21949477
[PubMed]
Free PMC Article
7.

Evolving pathophysiologic concepts in nonalcoholic steatohepatitis.

Neuschwander-Tetri BA.

Curr Gastroenterol Rep. 2002 Feb;4(1):31-6. Review.

PMID:
11825539
[PubMed - indexed for MEDLINE]
8.

[Nonalcoholic steatohepatitis--a "new" hepatic disease].

Grønbaek H, Eivindson MV, Hamilton-Dutoit S, Vilstrup H.

Ugeskr Laeger. 2003 Mar 10;165(11):1115-8. Review. Danish.

PMID:
12677985
[PubMed - indexed for MEDLINE]
9.

Non-alcoholic fatty liver disease.

Leclercq I.

Bull Mem Acad R Med Belg. 2010;165(3-4):147-55; discussion 155-8.

PMID:
21166266
[PubMed - indexed for MEDLINE]
10.

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.

Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.

PMID:
18459024
[PubMed - indexed for MEDLINE]
11.

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.

Stein LL, Dong MH, Loomba R.

Adv Ther. 2009 Oct;26(10):893-907. doi: 10.1007/s12325-009-0072-z. Epub 2009 Nov 16. Review.

PMID:
19921118
[PubMed - indexed for MEDLINE]
12.

Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.

Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H.

Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):259S-63S.

PMID:
16385233
[PubMed - indexed for MEDLINE]
13.

A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

Larter CZ, Chitturi S, Heydet D, Farrell GC.

J Gastroenterol Hepatol. 2010 Apr;25(4):672-90. doi: 10.1111/j.1440-1746.2010.06253.x. Review.

PMID:
20492324
[PubMed - indexed for MEDLINE]
14.

Non-alcoholic steatohepatitis.

Das K, Kar P.

J Assoc Physicians India. 2005 Mar;53:195-9. Review.

PMID:
15926603
[PubMed - indexed for MEDLINE]
15.

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Neuschwander-Tetri BA, Caldwell SH.

Hepatology. 2003 May;37(5):1202-19. Review. Erratum in: Hepatology. 2003 Aug;38(2):536.

PMID:
12717402
[PubMed - indexed for MEDLINE]
16.

Animal models of non-alcoholic steatohepatitis: of mice and man.

Schattenberg JM, Galle PR.

Dig Dis. 2010;28(1):247-54. doi: 10.1159/000282097. Epub 2010 May 7. Review.

PMID:
20460919
[PubMed - indexed for MEDLINE]
17.

Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.

Tiniakos DG.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):930-9. doi: 10.1016/j.gcb.2009.05.009. Epub 2009 Jul 30.

PMID:
19646834
[PubMed - indexed for MEDLINE]
Free Article
18.

The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.

Cong WN, Tao RY, Tian JY, Liu GT, Ye F.

Life Sci. 2008 May 7;82(19-20):983-90. doi: 10.1016/j.lfs.2008.01.022. Epub 2008 Mar 4.

PMID:
18417155
[PubMed - indexed for MEDLINE]
19.

Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH).

Agarwal N, Sharma BC.

Hepatol Res. 2005 Oct;33(2):92-6. Epub 2005 Sep 29.

PMID:
16198620
[PubMed]
20.

Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.

Lee SJ, Heinrich G, Fedorova L, Al-Share QY, Ledford KJ, Fernstrom MA, McInerney MF, Erickson SK, Gatto-Weis C, Najjar SM.

Gastroenterology. 2008 Dec;135(6):2084-95. doi: 10.1053/j.gastro.2008.08.007. Epub 2008 Aug 20.

PMID:
18848945
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk